Overall, results do seem good. They have met guidance across all key metrics.
Only 2 minor concerns:
- The growth has dipped QoQ. Need to track this going forward
- ROE has also dipped. Reason given was the QIP they did in Q3. So we need to track this to see if it improves as the AUM keeps growing. If it does, then there is nothing to worry about.
Note – Tracking as a potential investment candidate. So my views are biased.
Subscribe To Our Free Newsletter |